Krishnankutty Sudhir

Showing 1-14 of 14 articles

Author J. Ribamar Costa Jr

Coronary interventions

One-year clinical outcomes of patients treated with everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents: a propensity score comparison of patients enrolled in the ABSORB EXTEND and SPIRIT trials

Costa Jr J, Abizaid A, Bartorelli A, Whitbourn R, Jepson N, Perin M, Steinwender C, Stuteville M, Ediebah D, Sudhir K, Serruys P

November 20, 2016 | 10.4244/EIJV12I10A206

Author Alexandre Abizaid

The ABSORB EXTEND study: preliminary report of the twelve-month clinical outcomes in the first 512 patients enrolled

Abizaid A, Costa Jr J, Bartorelli A, Whitbourn R, van Geuns R, Chevalier B, Patel T, Seth A, Stuteville M, Dorange C, Cheong W-F, Sudhir K, Serruys P

April 20, 2015 | 10.4244/EIJV10I12A243

Author Giampaolo Niccoli

Incidence, time course and predictors of early vs. late target lesion revascularisation after everolimus-eluting stent implantation: a SPIRIT V substudy

Niccoli G, Stuteville M, Sudhir K, Li D, Montone R, Bolognese L, Grube E

July 26, 2013 | 10.4244/EIJV9I3A57

Author Masao Yamasaki

Comparison of vascular response to the everolimus-eluting stent versus the paclitaxel-eluting stent: intravascular ultrasound results from the SPIRIT III trial

Yamasaki M, Tsujino I, Lima-Filho M, Ako J, Shimohama T, Hasegawa T, Sakurai R, Sudhir K, Stone G, Waseda K, Honda Y, Fitzgerald P

October 26, 2012 | 10.4244/EIJV8I6A112

Author Elvin Kedhi

Stent thrombosis: insights on outcomes, predictors and impact of dual antiplatelet therapy interruption from the SPIRIT II, SPIRIT III, SPIRIT IV and COMPARE trials

Kedhi E, Stone G, Kereiakes D, Serruys P, Parise H, Fahy M, Simonton C, Sudhir K, Sood P, Smits P

September 28, 2012 | 10.4244/EIJV8I5A92

Author Marie-Claude Morice

SPIRIT Women, evaluation of the safety and efficacy of the XIENCE V everolimus-eluting stent system in female patients: referral time for coronary intervention and 2-year clinical outcomes

Morice M, Mikhail G, Mauri i Ferr F, Modena M, Strasser R, Grinfeld L, Sudhir K, Stuteville M, Papeleu P, Li D, Rutledge D, Windecker S

July 27, 2012 | 10.4244/EIJV8I3A51

Author James B. Hermiller

Impact of age on clinical outcomes after everolimus-eluting and paclitaxel-eluting stent implantation: pooled analysis from the SPIRIT III and SPIRIT IV clinical trials

Hermiller J, Sudhir K, Applegate R, Rizvi A, Wang J, Gordon P, Yaqub M, Cao S, Ferguson J, Smith R, Sood P, MPhil M, Stone G

May 15, 2012 | 10.4244/EIJV8I1A14

Author Robert Applegate

Predictors of early and late outcomes after everolimus and paclitaxel-eluting coronary stents

Applegate R, Hermiller J, Gordon P, Yaqub M, Sood P, Su X, Cao S, Sudhir K, Stone G

January 20, 2012 | 10.4244/EIJV7I9A165

Author James B. Hermiller

Clinical and angiographic outcomes of elderly patients treated with everolimus-eluting versus paclitaxel-eluting stents: three-year results from the SPIRIT III randomised trial

Hermiller J, Nikolsky E, Lansky A, Applegate R, Sanz M, Yaqub M, Sood P, Cao S, Sudhir K, Stone G

July 29, 2011 | 10.4244/EIJV7I3A54

Author Salvatore Brugaletta

Comparison between the first and second generation bioresorbable vascular scaffolds: a six month virtual histology study

Brugaletta S, Garcia-Garcia H, Diletti R, Gomez-Lara J, Garg S, Onuma Y, Shin E, van Geuns R, De Bruyne B, Dudek D, Thuesen L, Chevalier B, McClean D, Windecker S, Whitbourn R, Dorange C, Veldhof S, Rapoza R, Sudhir K, Bruining N, Ormiston J, Serruys P

April 20, 2011

Author Alexandra Lansky

Side branch occlusion with everolimus-eluting and paclitaxel-eluting stents: three-year results from the SPIRIT III randomised trial

Lansky A, Yaqub M, Hermiller J, Smith R, Farhat N, Caputo R, Williams J, Sanz M, Koo K, Sood P, Sudhir K, Stone G

January 11, 2011

Author Robert Applegate

Comparison of everolimus-eluting and paclitaxel-eluting coronary stents in patients with two treated vessels: 2-year results from the SPIRIT III randomised trial

Applegate R, Hermiller J, Sanz M, Doostzadeh J, Pierson W, Su X, Lansky A, Sudhir K, Stone G

September 30, 2010

Author Takayuki Okamura

In vivo evaluation of stent strut distribution patterns in the bioabsorbable everolimus-eluting device: an OCT ad hoc analysis of the revision 1.0 and revision 1.1 stent design in the ABSORB clinical trial

Okamura T, Garg S, Gutiérrez-Chico J-L, Shin E, Onuma Y, Garcia-Garcia H, Rapoza R, Sudhir K, Regar E, Serruys P

April 12, 2010

Author Ashok Seth

A pooled gender based analysis comparing the XIENCE V® everolimus-eluting stent and the TAXUS paclitaxel-eluting stent in male and female patients with coronary artery disease, results of the SPIRIT II and SPIRIT III studies: two-year analysis

Seth A, Serruys P, Lansky A, Hermiller J, Onuma Y, Miquel-Hebert K, Yu S, Veldhof S, Sood P, Sudhir K, Stone G

February 25, 2010

1

Latest news

Antiplatelet strategies for complex PCI, are all DES equal at 10-year follow-up? cost-effectiveness of TAVR…find all the answers in the new issue

(Intravascular lithotripsy (3.5 mm Shockwave; left), followed by balloon dilatation (4.0 mm NC; right))

December 6, 2019

The challenge of innovation for the (interventional?) cardiology world

December 6, 2019

This week's JAA's: EXTREME Study, Stent Optimization, Trifurcation disease and more

December 3, 2019

New update! Discover 17 new trials

(The Trials book is supported by Biotronik)

October 29, 2019

Guidance Papers

Guidelines, consensus & position papers

2019 – A leap year for valvular heart disease

(Course directors PCR London Valves 2019)

November 15, 2019

Last week's JAA's: DYNAMIC Trial, S3U registry and much more

November 26, 2019

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke